535 related articles for article (PubMed ID: 26511530)
1. Combined intravitreal melphalan and intravenous/intra-arterial chemotherapy for retinoblastoma with vitreous seeds.
Lee JH; Han JW; Hahn SM; Lyu CJ; Kim DJ; Lee SC
Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):391-4. PubMed ID: 26511530
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results.
Shields CL; Manjandavida FP; Arepalli S; Kaliki S; Lally SE; Shields JA
JAMA Ophthalmol; 2014 Mar; 132(3):319-25. PubMed ID: 24407202
[TBL] [Abstract][Full Text] [Related]
3. Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma.
Berry JL; Bechtold M; Shah S; Zolfaghari E; Reid M; Jubran R; Kim JW
Ophthalmology; 2017 Dec; 124(12):1817-1825. PubMed ID: 28655537
[TBL] [Abstract][Full Text] [Related]
4. INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture.
Shields CL; Douglass AM; Beggache M; Say EA; Shields JA
Retina; 2016 Jun; 36(6):1184-90. PubMed ID: 26630319
[TBL] [Abstract][Full Text] [Related]
5. Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma.
Ghassemi F; Shields CL; Ghadimi H; Khodabandeh A; Roohipoor R
JAMA Ophthalmol; 2014 Aug; 132(8):936-41. PubMed ID: 24789622
[TBL] [Abstract][Full Text] [Related]
6. Retinoblastoma Control With Primary Intra-arterial Chemotherapy: Outcomes Before and During the Intravitreal Chemotherapy Era.
Shields CL; Alset AE; Say EA; Caywood E; Jabbour P; Shields JA
J Pediatr Ophthalmol Strabismus; 2016 Sep; 53(5):275-84. PubMed ID: 27486728
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal chemotherapy in the management of vitreous disease in retinoblastoma.
Kiratli H; Koç İ; Varan A; Akyüz C
Eur J Ophthalmol; 2017 Jun; 27(4):423-427. PubMed ID: 28106239
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastoma.
Ghassemi F; Shields CL
Arch Ophthalmol; 2012 Oct; 130(10):1268-71. PubMed ID: 23044940
[TBL] [Abstract][Full Text] [Related]
9. Pathological findings in enucleated eyes after intravitreal melphalan injection.
Ghassemi F; Amoli FA
Int Ophthalmol; 2014 Jun; 34(3):533-40. PubMed ID: 24043335
[TBL] [Abstract][Full Text] [Related]
10. The classification of vitreous seeds in retinoblastoma and response to intravitreal melphalan.
Francis JH; Abramson DH; Gaillard MC; Marr BP; Beck-Popovic M; Munier FL
Ophthalmology; 2015 Jun; 122(6):1173-9. PubMed ID: 25795478
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal Lower-Dose (20 µg) Melphalan for Persistent or Recurrent Retinoblastoma Vitreous Seeds.
Tuncer S; Balcı Ö; Tanyıldız B; Kebudi R; Shields CL
Ophthalmic Surg Lasers Imaging Retina; 2015 Oct; 46(9):942-8. PubMed ID: 26469234
[TBL] [Abstract][Full Text] [Related]
12. Alternated intra-arterial and intravitreal chemotherapy for advanced intraocular retinoblastoma: preliminary successful results without systemic chemotherapy.
De Francesco S; Galluzzi P; Bracco S; Menicacci F; Motolese E; Hadjistilianou T
Int Ophthalmol; 2015 Dec; 35(6):887-95. PubMed ID: 26416040
[TBL] [Abstract][Full Text] [Related]
13. [Short-term efficacy of intravitreal injection of melphalan for refractory vitreous seeding from retinoblastoma].
Xue K; Ren H; Zhang R; Yuan YF; Qian J
Zhonghua Yan Ke Za Zhi; 2017 Aug; 53(8):570-574. PubMed ID: 28851196
[No Abstract] [Full Text] [Related]
14. Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications.
Munier FL; Gaillard MC; Balmer A; Soliman S; Podilsky G; Moulin AP; Beck-Popovic M
Br J Ophthalmol; 2012 Aug; 96(8):1078-83. PubMed ID: 22694968
[TBL] [Abstract][Full Text] [Related]
15. Diffuse chorioretinal atrophy after a single standard low- dose intravitreal melphalan injection in a child with retinoblastoma: a case report.
Chao A; Kao LY; Liu L; Wang NK
BMC Ophthalmol; 2016 Mar; 16():27. PubMed ID: 26975871
[TBL] [Abstract][Full Text] [Related]
16. Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds.
Shields CL; Bianciotto CG; Jabbour P; Ramasubramanian A; Lally SE; Griffin GC; Rosenwasser R; Shields JA
Arch Ophthalmol; 2011 Nov; 129(11):1399-406. PubMed ID: 21670328
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal chemotherapy provides control for massive vitreous seeding from retinoblastoma.
Lawson BM; Saktanasate J; Say EA; Shields CL
J Pediatr Ophthalmol Strabismus; 2014 Dec; 51 Online():e92-4. PubMed ID: 25490242
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal melphalan hydrochloride vs propylene glycol-free melphalan for retinoblastoma vitreous seeds: Efficacy, toxicity and stability in rabbits models and patients.
Bogan CM; Pierce JM; Doss SD; Tao YK; Chen SC; Boyd KL; Liao A; Hsieh T; Abramson DH; Francis JH; Friedman DL; Richmond A; Daniels AB
Exp Eye Res; 2021 Mar; 204():108439. PubMed ID: 33444583
[TBL] [Abstract][Full Text] [Related]
19. Minimal exposure (one or two cycles) of intra-arterial chemotherapy in the management of retinoblastoma.
Shields CL; Kaliki S; Shah SU; Bianciotto CG; Liu D; Jabbour P; Griffin GC; Shields JA
Ophthalmology; 2012 Jan; 119(1):188-92. PubMed ID: 21975042
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal injection of melphalan for intraocular retinoblastoma.
Suzuki S; Aihara Y; Fujiwara M; Sano S; Kaneko A
Jpn J Ophthalmol; 2015 May; 59(3):164-72. PubMed ID: 25808017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
